Can a vaccine built for one Ebola virus stop another? The World Health Organization is about to find out

The World Health Organization (WHO) has recommended prioritizing the Ervebo vaccine for investigating successful a objective proceedings successful the Democratic Republic of the Congo. The vaccine was primitively developed to support against Zaire ebolavirus, the taxon liable for the devastating West African epidemic conscionable implicit a decennary ago. It was not designed for the Bundibugyo taxon liable for the existent outbreak—which raises the question of wherefore scientists are considering it astatine all.